Vicore Pharma Holding AB (publ)

DB:6Y4 Stock Report

Market Cap: €192.7m

Vicore Pharma Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6Y4?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders10,996,4164.69%
Public Companies14,571,4286.21%
VC/PE Firms16,465,7747.02%
Institutions59,311,70325.3%
General Public133,233,79856.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 110%.

Top Shareholders

Top 25 shareholders own 43.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.02%
Odlander, Fredrikson & Co. AB
16,465,774€13.5m-10.7%11.71%
6.21%
Sanofi
14,571,428€12.0m0%no data
5.01%
Capital Research and Management Company
11,752,536€9.7m0%no data
4.67%
Fourth Swedish National Pension Fund (AP4)
10,960,399€9.0m0%0.04%
4.64%
HBM Partners Ltd.
10,874,727€8.9m0%0.95%
1.78%
Tredje AP-fonden
4,184,779€3.4m0%0.02%
1.71%
Goran Wessman
4,000,340€3.3m0%no data
1.61%
Unionen, Endowment Arm
3,782,539€3.1m0%0.93%
1.46%
Avanza Fonder AB
3,431,740€2.8m0%0.04%
1.43%
C WorldWide Asset Management Fondsmaeglerselskab A/S
3,350,000€2.8m0%0.02%
1.15%
Jesper Lyckeus
2,697,000€2.2m0%no data
1.03%
Swedbank Robur Fonder AB
2,407,163€2.0m0%no data
0.95%
The Invus Group, LLC
2,227,200€1.8m0%6.96%
0.87%
Handelsbanken Asset Management
2,050,728€1.7m0%no data
0.69%
Kjell Stenberg
1,623,303€1.3m0%no data
0.69%
SEB Investment Management AB
1,607,877€1.3m48%no data
0.59%
Karl Perlhagen
1,373,861€1.1m0%no data
0.31%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
721,715€592.9k0%0.13%
0.23%
Andra AP-fonden
528,754€434.4k0%no data
0.22%
Max Mitteregger
525,000€431.3k0%no data
0.2%
Carl-Johan Dalsgaard
477,981€392.7k0%no data
0.18%
FundLogic SAS
423,387€347.8k0%0.02%
0.14%
Towarzystwo Funduszy Inwestycyjnych PZU SA
339,276€278.7k0%0.02%
0.13%
AXA Towarzystwo Funduszy Inwestycyjnych SA
308,240€253.2k0%0.06%
0.13%
FCG Fonder AB
294,895€242.3k0%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 12:34
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vicore Pharma Holding AB (publ) is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hanseung YooBryan Garnier & Co
Oscar Haffen LammBryan Garnier & Co
Patrik LingDNB Markets